ctrl K

Watchlist Price Alert

Nuvectis Pharma Inc. (NVCT)

NASDAQ: NVCT · Real-Time Price · USD

9.17

-0.45 (-4.68%)

At close: May 02, 2025, 3:59 PM

9.40

2.51%

After-hours: May 02, 2025, 05:05 PM EDT

Nuvectis Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.53M	19.13M	19.99M	5.74M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	824K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	74K	59K	412K	91K	n/a
Total Current Assets	18.61M	19.18M	20.41M	5.83M	n/a
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	824K	n/a
Total Assets	18.61M	19.18M	20.41M	6.66M	n/a
Account Payables	2.5M	2.77M	2.91M	1.06M	10K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5.56M	3.8M	450K	824K	n/a
Total Current Liabilities	8.89M	6.98M	6.19M	2.42M	10K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.91M	15.25M	n/a
Total Liabilities	8.89M	6.98M	6.19M	17.66M	10K
Total Debt	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	14.75B	n/a	n/a
Retained Earnings	-73.25M	-54.24M	-31.98M	-12.9M	-10K
Comprehensive Income	n/a	n/a	-14.75B	0.00	n/a
Shareholders Equity	9.71M	12.2M	14.22M	-11.01M	-10K
Total Investments	n/a	n/a	n/a	n/a	n/a